SCHEMBL740769

SCHEMBL740769

N[C@@H](Cc1ccccn1)C(=O)N1CCCC(c2nc3ccccc3[nH]2)C1

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
DPP4 P27487 1/20 0.50
HTR2B P41595 5/20 0.48
KDM4E B2RXH2 3/20 0.47
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741246 0.87 POLB (0.53) POLBHTR2BKDM4EMAPK1CYP1A2
SCHEMBL763405 0.87 POLB (0.53) POLBHTR2BKDM4EMAPK1CYP1A2
SCHEMBL738586 0.84 POLB (0.55) POLBHTR2BKDM4EMAPK1CYP1A2
SCHEMBL740722 0.84 POLB (0.60) POLBHTR2BKDM4EMAPK1HSD17B10
SCHEMBL738241 0.83 POLB (0.56) POLBHTR2BKDM4EMAPK1HSD17B10
SCHEMBL739966 0.81 POLB (0.58) POLBHTR2BKDM4EMAPK1CYP1A2
SCHEMBL738959 0.81 POLB (0.58) POLBHTR2BKDM4EMAPK1CYP1A2
SCHEMBL739172 0.79 POLB (0.56) POLBHTR2BKDM4EMAPK1CYP1A2
SCHEMBL740792 0.79 HTR2B (0.54) POLBDPP4HTR2BKDM4EMAPK1
SCHEMBL742129 0.79 POLB (0.55) POLBHTR2BKDM4EMAPK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed